TIM-3 Alzheimer’s treatment is emerging as a promising avenue in the fight against Alzheimer's disease, leveraging insights from cancer immunotherapy.Researchers have identified TIM-3, a checkpoint inhibitor, as a crucial player in regulating the immune response within the brain.